Skip to main content
Article
Thalidomide-Resistant HIV-Associated Aphthae Successfully Treated With Granulocyte Colony-Stimulating Factor.
Journal of the American Academy of Dermatology
  • Steven M Manders, MD
  • Jay R Kostman, MD
  • Leonardo Mendez, MD
  • Victoria A Loven, Lehigh Valley Health Network
Publication/Presentation Date
8-1-1995
Abstract

Thalidomide has been advocated as the treatment of choice for recalcitrant aphthae. We describe the case of patient with HIV infection and extensive aphthae whose condition failed to respond to corticosteroids, cyclosporine, and thalidomide. The patient's course was complicated by colonic aphthae. Rapid and sustained resolution was achieved through treatment with granulocyte colony-stimulating factor, a previously unreported therapeutic option.

Disciplines
PubMedID
7542291
Document Type
Article
Citation Information

Manders, S. M., Kostman, J. R., Mendez, L., & Russin, V. L. (1995). Thalidomide-resistant HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor. Journal Of The American Academy Of Dermatology, 33(2 Pt 2), 380-382.